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Nonsteroidal anti-inflammatory drugs (NSAIDs) belong to a class of drugs used
worldwide for the treatment of pain, fever and inflammatory diseases. Relatively new
findings indicating that long-term use of NSAIDs is associated with lower risk of some
types of cancer (1, 2) initiated a growing interest in this class of drugs. Numerous NSAID
derivatives have been prepared in order to improve analgesic/anti-inflammatory activ-
ity, minimize side effects, prolong plasma half-life, increase COX1/COX2 selectivity, cyto-
static activity and change water solubility or lipophilicity (3–5). However, our research is
directed towards NSAID prodrugs and NSAID derivatives with dual cyclooxygenase/
5-lipoxygenase inhibition or potential antioxidative and cytostatic activity. In this light,
we have prepared and pharmacologically evaluated numerous amides (6, 7), phosphor-
amidate derivatives (8), semicarbazides and hydroxycarbamoylcarbazides (9), hydroxa-
mic acid NSAID derivatives (10, 11) and polymer-NSAID conjugates (12, 13). Here, we
describe syntheses of novel NSAID esters, derivatives of ibuprofen, ketoprofen and di-
clofenac, containing amino acid residue, urea and amide moieties, as potential NSAID
prodrugs.
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A convenient synthetic method for the preparation of
novel NSAID twin esters 6a–i containing amino acid res-
idue, urea and amide moieties has been developed. The
synthetic pathway applied for the preparation of target
compounds and key intermediates 1-benzotriazolecarbo-
xylic acid chloride (1), NSAID benzotriazolides 2a–c and
N-(1-benzotriazolecarbonyl)-amino acids 3a–d involved
benzotriazole as a synthetic auxiliary. The final prepara-
tion step of esters 6a–i included the solvent-free reaction
of compounds 2a–c with amino acid derivatives 5a–g,
bearing two hydroxyl groups, one at each terminal, be-
side urea and amide functionalities.
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EXPERIMENTAL
Materials and methods
IR spectra were recorded on a FTIR Perkin Elmer Paragon 500 spectrometer (Perkin-
-Elmer, UK). 1H and 13C NMR spectra were recorded on a Varian Gemini 300 spectrome-
ter (Varian, USA), operating at 300 and 75.5 MHz for 1H and 13C nuclei, respectively.
Samples were measured in DMSO-d6 solutions at 20 °C in 5-mm NMR tubes. Chemical
shifts (d) in ppm were referred to TMS. Elemental analyses were performed on a CHNS
LECO analyzer (LECO Corporation, USA). Solvent systems cyclohexane/ethyl acetate
(1:1), cyclohexane/ethyl acetate/methanol (3:1:0.5), ethyl acetate/cyclohexane/metha-
nol (3:1:0.1) and dichloromethane/methanol (9.5:0.5 and 9:1) and precoated Merck silica
gel 60 F254 plates (Merck, Germany) were used for thin-layer chromatography (TLC).
Spots were visualized by short-wave UV light and iodine vapour. Column chromatogra-
phy was performed on silica gel (0.063–0.200 mm) (Kemika, Croatia), with dichloro-
methane/methanol (9.5:0.5), cyclohexane/ethyl acetate/methanol (3:1:0.5) and cyclo-
hexane/ethyl acetate (1:1) as eluents. Benzotriazole (BtH), triphosgene, 2-aminoethanol
(ethanolamine), 3-aminopropanol, 5-aminopenthanol and triethylamine (TEA) were pur-
chased from Aldrich (USA). Amino acids were purchased from Kemika, while ibuprofen,
ketoprofen and diclofenac were from Pliva and Belupo (Croatia).
Benzotriazole carboxylic acid chloride (1) (14), ibuprofen-benzotriazolide (2a), keto-
profen-benzotriazolide (2b), diclofenac-benzotriazolide (2c) (12), N-(1-benzotriazolecarbo-
nyl)-L-alanine (3a), N-(1-benzotriazolecarbonyl)-L-leucine (3b), N-(1-benzotriazolecar-
bonyl)-D-phenylglycine (3c), N-(1-benzotriazolecarbonyl)-L-phenylalanine (3d) (15) and
L-alanine/3-aminopropanol (5a), L-leucine/3-aminopropanol (5b), L-leucine/5-amino-
penthanol (5c), D-phenylglycine/2-aminoethanol (5d), D-phenylglycine/5-aminopen-
thanol (5e), L-phenylalanine/2-aminoethanol (5f), L-phenylalanine/3-aminopropanol
(5g) ureidoamides (9) were prepared according to our procedures published earlier.
Syntheses of compounds 6a–i. General procedure
A solvent free mixture prepared from NSAID benzotriazolide 2a–c (1 mmol), the cor-
responding ureidoamide 5a–g (0.5 mmol) and TEA (0.202 g, 2 mmol) was heated until
melting occurred (100–125 °C) and kept at that temperature for 15 minutes. The reaction
mixture prepared was cooled, dissolved in 30 mL ethyl acetate and extracted three times
with sodium hydroxide solution (3 × 30 mL of water and 10 drops of 5 % NaOH), washed
with water, dried over anhydrous sodium sulphate, filtered and evaporated under re-
duced pressure. Crude products were purified by column chromatography. Analytical
and spectral data of synthesized esters 6a–i are given in Tables I and II.
2-(4-Isobutyl-phenyl)-propionic acid 5-[2-(3-/5-[2-(4-isobutyl-phenyl)-
-propionyloxy]-pentyl/-ureido-2-phenyl-acetylamino]-pentyl ester (6a)
Amixture prepared from 0.307 g ibuprofen derivative (2a), 0.181 g D-phenylglycine
5-aminopenthanol ureidoamide (5e) and TEA was heated at 100 °C. Dichloromethane/
methanol 9.5:0.5 was used as eluent for column chromatography.
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Amixture prepared from 0.307 g ibuprofen derivative (2a), 0.162 g L-phenylalanine
3-aminopropanol ureidoamide (5g) and TEA was heated at 100 °C. Dichloromethane/
methanol 9.5:0.5 was used for column chromatography.
2-(3-Benzoyl-phenyl)-propionic acid 3-[2-(3-/3-[2-(3-benzoyl-phenyl)-
-propionyloxy]-propyl/-ureido)-propionylamino]-propyl ester (6c)
Ketoprofen derivative (2b, 0.355 g) in a mixture with L-alanine 3-aminopropanol ure-
idoamide (5a, 0.124 g) and TEA was heated at 125 °C. Dichloromethane/methanol 9.5:0.5
was used for column chromatography.
2-(3-Benzoyl-phenyl)-propionic acid 3-[2-(3-/3-[2-(3-benzoyl-phenyl)-propionyloxy]-
-propyl/-ureido)-4-methyl-pentanoylamino]-propyl ester (6d)
Ketoprofen derivative (2b, 0.355 g) was mixed with L-leucine 3-aminopropanol ure-
idoamide (5b, 0.145 g) and TEA. The mixture was heated at 100 °C. Cyclohexane/ethyl
acetate 1:1 was used as eluent for column chromatography.
2-(3-Benzoyl-phenyl)-propionic acid 5-[2-(3-/5-[2-(3-benzoyl-phenyl)-propionyloxy]-
-pentyl/-ureido)-4-methyl-pentanoylamino]-pentyl ester (6e)
The titled compound was prepared from a mixture of 0.355 g ketoprofen derivative
(2b), 0.173 g L-leucine 5-aminopenthanol ureidoamide (5c) and TEA heated at 100 °C.




To synthesize the title compound, a mixture of 0.355 g ketoprofen derivative (2b),
0.141 g D-phenylglycine 2-aminoethanol ureidoamide (5d) and TEA was heated at 115
°C. Ethyl acetate/cyclohexane/methanol 3:1:0.1 was used as eluent for purification of
the crude product by column chromatography.
2-(3-Benzoyl-phenyl)-propionic acid 2-[2-(3-/2-[2-(3-benzoyl-phenyl)-propionyloxy]-
-ethyl/-ureido)-3-phenyl-propionylamino]-ethyl ester (6g)
A mixture prepared from 0.355 g ketoprofen derivative (2b), 0.148 g L-phenylala-
nine 2-aminoethanol ureidoamide (5f) and TEA was heated at 100 °C. Ethyl acetate/
cyclohexane/methanol 3:1:0.1 was used for column chromatography purification.
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Ketoprofen derivative (2b, 0.355 g) was mixed with 0.162 g L-phenylalanine 3-ami-
nopropanol ureidoamide (5g) and TEA. The mixture was heated at 120 °C. The crude
product was purified on the chromatographic column using ethyl acetate/cyclohexane/




A mixture of 0.397 g diclofenac derivative (2c), 0.162 g L-phenylalanine 3-amino-
propanol ureidoamide (5g) and TEA was heated at 100 °C. Column chromatography
with dichloromethane/methanol 9.5:0.5 as eluent was used for purification of the crude
product.
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3302, 2915, 1732, 1650, 1570, 1460,





3300, 2916, 1732, 1644, 1568, 1464,





3302, 3065, 2927, 2869, 1731, 1659,
1635, 1569, 1556, 1449, 1380, 1318,
1284, 1250, 1206, 1173, 1079, 960,
719, 644
C42H45N3O8
(719.82) 70.08/69.77 6.30/5.94 5.84/5.95
6d 90
3300, 3060, 2950, 1736, 1650, 1558,
1448, 1378, 1284, 1176, 1076, 954,
704, 642
C46H55N3O8
(777.94) 71.02/70.79 7.13/7.00 5.40/5.75
6e 73
3291, 3064, 2932, 2869, 1732, 1659,
1633, 1566, 1556, 1448, 1378, 1318,
1283, 1206, 1176, 1077, 954, 721,
706, 643
C49H59N3O8
(818.01) 71.95/72.16 7.27/7.54 5.14/5.44
6f 65
3296, 3064, 2980, 1735, 1633, 1564,





3302, 3063, 2979, 2938, 1732, 1663,
1646, 1569, 1554, 1451, 1380, 1284,
1205, 1177, 1078, 956, 823, 722, 644
C46H45N3O8
(767.86) 71.95/72.31 5.91/6.04 5.47/5.78
6h 68
3300, 3050, 2940, 1736, 1654, 1560,





3300, 3090, 2850, 1718, 1650, 1566,
1508, 1452, 1238, 1142, 1092, 775,
744, 700
C44H43Cl4N5O6
(879.65) 60.08/60.41 4.93/4.52 7.96/7.61
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Synthesis of novel NSAID twin esters 6a–i containing amino acid residue, urea and
amide moieties is described. The synthetic pathway applied for the preparation of target
compounds is presented in Scheme 1. The key intermediates 1-benzotriazolecarboxylic
acid chloride (1), NSAID benzotriazolides 2a–c, N-(1-benzotriazolecarbonyl)-amino acids
3a–d and ureidoamides 5a–g were prepared according to our procedures reported else-
where (9, 12, 14, 15). 1-Benzotriazolecarboxylic acid chloride (1) was synthesized from
benzotriazole and triphosgene (14) and further used in the preparation of N-(1-benzo-
triazolecarbonyl)-amino acids 3a–d (15). Two aliphatic (L-alanine, L-leucine) and two aro-
matic (D-phenylglycine, L-phenylalanine) amino acids were used in experiments. The
prepared amino acid derivatives 3a–d were transformed to the corresponding chlorides
4a–d by means of thionyl chloride. In the reaction with aminoalcohols (2-aminoethanol,
3-aminopropanol or 5-aminopenthanol), they gave ureidoamides 5a–g (9). 1-Benzotriazo-
lecarboxylic acid chloride (1) was also used in the preparation of ibuprofen (2a), keto-
profen (2b) and diclofenac benzotriazolide (2c) (12). The benzotriazole moiety in com-
pounds 2a–c activated the nucleophilic substitution of molecules with hydroxyl groups
present in ureido amides 5a–g, allowing preparation of the final esters 6a–i.
Structures of compounds 6a–i were deduced from analyses of their IR, 1H and 13C
NMR spectra and were confirmed by elemental analysis (Table I). Chemical shifts were
consistent with the proposed structures of novel compounds. IR spectra of esters 6a–i
showed characteristic bands for NH at 3302–3291 cm–1 and three different carbonyl groups
at 1736–1718, 1663–1633 and 1570–1556 cm–1, respectively. In 1H NMR spectra, carbamide
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NH-1’ appeared as triplets between 6.61 and 5.92 ppm, while the NH-3 proton appeared
as a doublet between 6.84 and 5.87 ppm. Amide NH-1’ appeared as a triplet between
8.47 and 7.87 ppm. All three NH groups were exchangeable with D2O. Ester carbonyls
C-1« in 13C NMR spectra appeared as only one or two very close signals between 175.91
and 172.09 ppm. Amide C-1 atom was located between 173.67 and 170.92 ppm, while
urea carbonyl C-4 appeared between 158.14 and 157.17 ppm. Ketoprofen derivatives
6c–h showed additional carbonyl C-10« uniformly located at 196 ppm. Detailed NMR
data of all new compounds are given in Table II.
CONCLUSIONS
The environmentally friendly solvent-free protocol for synthesis of novel NSAID es-
ters containing amino acid residue, urea and amide moieties has been described. The
prepared esters are potential NSAID prodrugs. Their analgesic, anti-inflammatory and
antioxidative activities still remain to be evaluated.
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